2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
262
Thoracic
1
Gastrointestinal
1
Dermatologic
1
Conditions
Colorectal Neoplasms
5925
Pancreatic Neoplasms
3552
Carcinoma, Hepatocellular
3264
Stomach Neoplasms
3051
Colonic Neoplasms
2326
Rectal Neoplasms
2186
Esophageal Neoplasms
1797
Liver Neoplasms
1246
Neoplasms
1179
Breast Neoplasms
1062
Neoplasm Metastasis
867
Carcinoma, Non-Small-Cell Lung
789
Lung Neoplasms
743
Cholangiocarcinoma
737
Gastrointestinal Neoplasms
661
Ovarian Neoplasms
628
Esophageal Squamous Cell Carcinoma
581
Prostatic Neoplasms
483
Melanoma
457
Biliary Tract Neoplasms
438
Head and Neck Neoplasms
376
Uterine Cervical Neoplasms
342
Carcinoma, Renal Cell
327
Gastrointestinal Stromal Tumors
324
Adenocarcinoma Of Esophagus
315
Sarcoma
303
Barrett Esophagus
300
Anus Neoplasms
284
Gallbladder Neoplasms
281
Urinary Bladder Neoplasms
280
Interventions
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Gastrointestinal
×
Clear all
NCT06448364
2024-11-06
LTbR
Pfizer
Phase 1
Terminated
4 enrolled